XML 36 R30.htm IDEA: XBRL DOCUMENT

Revenue from contracts with customers (Tables)

9 Months Ended

Sep. 30, 2025

Summary of disaggregates revenues by major revenue streams

The following table disaggregates Teva’s revenues by major revenue streams. For additional information on disaggregation of revenues, see note 15.


		Three months ended September 30, 2025
		United States				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			2,063				1,207				512				125				3,907
Licensing arrangements			27				11				5				3				46
Distribution			392				§				14				—				406
Other			§				16				26				78				121

		$	2,483			$	1,235			$	557			$	205			$	4,480

§	Represents an amount less than $0.5 million.


		Three months ended September 30, 2024
		United States				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			1,822				1,214				568				121				3,725
Licensing arrangements			23				9				6				8				45
Distribution			380				§				10				—				390
Other			§				42				29				100				172

		$	2,225			$	1,265			$	613			$	229			$	4,332

§	Represents an amount less than $0.5 million.


		Nine months ended September 30, 2025
		United States				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			5,332				3,681				1,535				389				10,937
Licensing arrangements			78				27				20				3				128
Distribution			1,130				1				36				—				1,167
Other			3				18				43				251				314

		$	6,543			$	3,726			$	1,634			$	644			$	12,547


		Nine months ended September 30, 2024
		United States				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			4,857				3,668				1,708				399				10,632
Licensing arrangements			68				26				17				10				121
Distribution			1,134				§				28				—				1,163
Other			§				54				49				295				399

		$	6,060			$	3,749			$	1,802			$	703			$	12,315

§	Represents an amount less than $0.5 million.

Summary of Sales Reserves and Allowances


		Sales Reserves and Allowances
		Reserves included in Accounts Receivable, net				Rebates				Medicaid and other governmental allowances				Chargebacks				Returns				Other				Total reserves included in Sales Reserves and Allowances				Total
		(U.S.$ in millions)
Balance at January 1, 2025		$	56			$	1,674			$	561			$	936			$	399			$	108			$	3,678			$	3,734
Provisions related to sales made in current year period			310				3,746				753				6,012				213				120				10,844				11,154
Provisions related to sales made in prior periods			—				(38	)			33				(29	)			(3	)			(11	)			(48	)			(48	)
Credits and payments			(295	)			(3,432	)			(701	)			(6,062	)			(168	)			(93	)			(10,456	)			(10,751	)
Translation differences							61				16				18				5				16				116				116

Balance at September 30, 2025		$	71			$	2,011			$	662			$	875			$	446			$	140			$	4,134			$	4,205


		Sales Reserves and Allowances
		Reserves included in Accounts Receivable, net				Rebates				Medicaid and other governmental allowances				Chargebacks				Returns				Other				Total reserves included in Sales Reserves and Allowances				Total
		(U.S.$ in millions)
Balance at January 1, 2024		$	61			$	1,603			$	540			$	859			$	436			$	97			$	3,535			$	3,596
Provisions related to sales made in current year period			294				3,436				579				5,925				191				146				10,277				10,571
Provisions related to sales made in prior periods			—				16				26				(11	)			(28	)			(2	)			1				1
Credits and payments			(292	)			(3,269	)			(556	)			(5,877	)			(209	)			(121	)			(10,032	)			(10,324	)
Translation differences			—				1				3				1				(1	)			—				4				4

Balance at September 30, 2024		$	63			$	1,787			$	592			$	897			$	389			$	120			$	3,785			$	3,848